1. Home
  2. ADXN vs AMBO Comparison

ADXN vs AMBO Comparison

Compare ADXN & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADXN
  • AMBO
  • Stock Information
  • Founded
  • ADXN 2002
  • AMBO 2000
  • Country
  • ADXN Switzerland
  • AMBO United States
  • Employees
  • ADXN N/A
  • AMBO N/A
  • Industry
  • ADXN Biotechnology: Pharmaceutical Preparations
  • AMBO Other Consumer Services
  • Sector
  • ADXN Health Care
  • AMBO Real Estate
  • Exchange
  • ADXN Nasdaq
  • AMBO Nasdaq
  • Market Cap
  • ADXN 8.0M
  • AMBO 10.5M
  • IPO Year
  • ADXN N/A
  • AMBO 2010
  • Fundamental
  • Price
  • ADXN $10.24
  • AMBO $3.72
  • Analyst Decision
  • ADXN Strong Buy
  • AMBO
  • Analyst Count
  • ADXN 1
  • AMBO 0
  • Target Price
  • ADXN $30.00
  • AMBO N/A
  • AVG Volume (30 Days)
  • ADXN 61.3K
  • AMBO 24.4K
  • Earning Date
  • ADXN 09-01-2025
  • AMBO 08-05-2025
  • Dividend Yield
  • ADXN N/A
  • AMBO N/A
  • EPS Growth
  • ADXN N/A
  • AMBO N/A
  • EPS
  • ADXN 0.10
  • AMBO 0.69
  • Revenue
  • ADXN $278,508.00
  • AMBO $9,699,000.00
  • Revenue This Year
  • ADXN $86.57
  • AMBO N/A
  • Revenue Next Year
  • ADXN N/A
  • AMBO N/A
  • P/E Ratio
  • ADXN $0.84
  • AMBO $5.39
  • Revenue Growth
  • ADXN N/A
  • AMBO 23.73
  • 52 Week Low
  • ADXN $6.51
  • AMBO $1.00
  • 52 Week High
  • ADXN $12.05
  • AMBO $5.55
  • Technical
  • Relative Strength Index (RSI)
  • ADXN 62.42
  • AMBO 59.03
  • Support Level
  • ADXN $8.88
  • AMBO $3.44
  • Resistance Level
  • ADXN $10.85
  • AMBO $3.81
  • Average True Range (ATR)
  • ADXN 0.52
  • AMBO 0.34
  • MACD
  • ADXN 0.27
  • AMBO 0.01
  • Stochastic Oscillator
  • ADXN 58.43
  • AMBO 90.00

About ADXN Addex Therapeutics Ltd

Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is an AI-driven technology educational company. Along with its subsidiaries, the company is developing a new HybriU AI Digital Education Solution that transforms the educational environment, bridging the gap between traditional methods and the future of digital learning. The solution combines sophisticated software and hardware to create an AI-powered digital and hybrid classroom, designed to enhance educational delivery and engagement. In addition, the group offers high-quality, individualized, and dynamic career education services and products through the operation of its for-profit colleges. Substantially the majority of the group's revenues are derived from the United States, based on the geographical locations where services are provided to customers.

Share on Social Networks: